Involvement of beta(1) integrin in betaAP-induced apoptosis in human neuroblastoma cells.
D000544:Alzheimer Disease / Q000378:metabolism* / Q000503:physiopathology; D016229:Amyloid beta-Peptides / Q000633:toxicity*; D000906:Antibodies / Q000494:pharmacology; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology*; D001921:Brain / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D002448:Cell Adhesion / Q000187:drug effects / Q000502:physiology; D045744:Cell Line, Tumor; D002470:Cell Survival / Q000187:drug effects / Q000502:physiology; D015536:Down-Regulation / Q000187:drug effects / Q000502:physiology; D016326:Extracellular Matrix Proteins / Q000378:metabolism / Q000494:pharmacology; D006801:Humans; D039001:Integrin alpha Chains / Q000187:drug effects / Q000378:metabolism; D039222:Integrin alpha1beta1 / Q000187:drug effects / Q000378:metabolism; D019012:Integrin beta1 / Q000187:drug effects / Q000378:metabolism*; D009447:Neuroblastoma; D009474:Neurons / Q000378:metabolism* / Q000473:pathology; D010446:Peptide Fragments / Q000633:toxicity; D021122:Protein Subunits / Q000187:drug effects / Q000378:metabolism
D016229:Amyloid beta-Peptides; D000906:Antibodies; D016326:Extracellular Matrix Proteins; D039001:Integrin alpha Chains; D039222:Integrin alpha1beta1; D019012:Integrin beta1; D010446:Peptide Fragments; D021122:Protein Subunits; C075222:amyloid beta-protein (1-42); C074636:amyloid beta-protein (25-35)